Navigation Links
Promidian Survey Finds Growing Support for Patient-Centered Medical Home
Date:3/29/2011

BERKELEY HEIGHTS, N.J., March 29, 2011 /PRNewswire/ -- Promidian, a management consulting firm focused on the pharmaceutical and biotechnology industries, today announced top-line survey findings about the increasing interest in the patient-centered medical home (PCMH), a patient-centric delivery-of-care model that is rapidly gaining nationwide attention for its potential to improve quality and access to health care—while reducing costs.

The Promidian PCMH survey was completed in March 2011 and included a nationwide mix of 181 stakeholders, including physicians, medical directors, nurses, and administrators and executives from medical group practices, health plans, pharmaceutical companies, and employer groups. The survey found that

  • Patient engagement in care, access to care, and a team approach to care are viewed as the most important components of a PCMH;
  • Priority disease states highlighted by PCMHs include diabetes, cardiovascular disease, asthma, obesity, and stroke;
  • Medication adherence is viewed as extremely important to the success of a PCMH, and PCMHs are considering and evaluating a number of tactics to improve medication adherence;
  • The vast majority of PCMH representatives are interested in receiving targeted resources to help achieve or maintain accreditation (eg, programs, tools, and training).

"Our survey identified a number of key priorities and challenges for PCMHs, as well as highlighted opportunities for pharmaceutical companies to positively influence and support the evolution of this innovative care delivery model," said Kevin Barnett, Executive Vice President and Managing Director for Promidian.

The complete results of the survey will be available at the Promidian exhibit booth at the Patient-Centered Primary Care Collaborative (PCPCC) Conference on March 29-31, at the Ronald Reagan Building, International Trade Center in Washington, DC.

About Promidian

Promidian is a management consulting firm that is focused on the pharmaceutical, biotechnology, and life sciences industries. We combine deep industry and functional area knowledge with specialized expertise in market assessment, analytics, and strategy development—to assist life sciences executives in addressing their most pressing business challenges.

For more information on the PCMH survey or to learn more about Promidian's service offerings, please contact Kevin Barnett, Executive Vice President, at kbarnett@promidianconsulting.com, or visit our Web site at www.promidianconsulting.com.

Promidian is a company of the Access Group (www.theaccessgroup.com).


'/>"/>
SOURCE Promidian
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Survey Emphasizes Value of Biopharmaceutical Company Engagement With Healthcare Providers
2. New Nationwide Survey Identifies Need for Increased Dialogue Between Gastroesophageal Reflux Disease or Frequent Heartburn Sufferers and Health Care Providers
3. National Nasal Allergy Survey Reveals Unmet Needs Still Exist Among Patients Living With Allergic Rhinitis
4. Survey Sampling International Names Chris DeAngelis to Head New SSI Health
5. Reportlinker Adds Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011
6. Thats Nice LLC Launches Nice Insight Marketing Intelligence for CRAMs With Its Pharma & Biotech Outsourcing Survey
7. Survey Finds Patients Oppose Prescription Mandate for OTC Medicines Containing Pseudoephedrine
8. Sixty Percent of Surveyed Type 2 Diabetes Patients in the U.S. Who Use Insulin Indicate They Would Request a Switch to a Less Expensive Biosimilar Insulin if Such an Agent Became Available
9. On Average, 55 Percent of Surveyed U.S. Asthma Patients Say They Are Likely to Request a Switch to a Drug With Efficacy Comparable to Their Current Medication but Which is Dosed Just Once a Day
10. Reportlinker Adds Healthcare Reform: 2010 Medical Device Industry Perceptions Survey
11. A Majority of Surveyed PCPs and Endocrinologists Indicate that they will Prescribe Contrave, Lorqess and Qnexa if these Therapies are Approved for Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: ... and sells medical devices and wearable sleep respiratory products ... cooperation agreement with Hongyuan Supply Chain Management Co., Ltd. ... 20, 2016, to develop Dehaier,s new Internet medical technology ... will leverage Hongyuan Supply Chain,s sales platform to reach ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
Breaking Medicine News(10 mins):